Stay updated on ELiSA Study: Lixivaptan in ADPKD Clinical Trial
Sign up to get notified when there's something new on the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page.

Latest updates to the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page
- Check2 days agoChange DetectedA new revision tag, v3.5.4, was added to the page's revision history, replacing the previous v3.5.3. This indicates an update to the page's versioning and metadata rather than changes to study content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision entry v3.5.3 was added to the study's record history, replacing the prior v3.5.2, indicating an update to the page version rather than changes to the study data.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.5.2 added and v3.5.0 removed on the Record History page.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded revision v3.5.0 to the Record History and removed revision v3.4.3.SummaryDifference0.1%

- Check67 days agoChange DetectedA new revision entry (v3.4.3) was added to the record history, replacing the previous revision (v3.4.2).SummaryDifference0.1%

- Check95 days agoChange DetectedA new system revision entry (Revision: v3.4.2) has been added. The older funding-notice banner and Revision: v3.4.1 have been removed.SummaryDifference0.6%

Stay in the know with updates to ELiSA Study: Lixivaptan in ADPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page.